During open submission periods, program developers can submit their interventions for potential review and inclusion on this Web site. The last open submission period was held from January 2 through February 28, 2014. This page provides information about minimum requirements for review, ineligible interventions, and where to go for more information about the open submission process and minimum requirements.
To be eligible for NREPP review, an intervention must meet the following minimum requirements:
- The intervention has produced one or more positive behavioral outcomes (p ≤ .05) in mental health or substance abuse among individuals, communities, or populations. Significant differences between groups over time must be demonstrated for each outcome.
- Evidence of the positive behavioral outcome(s) has been demonstrated in at least one study using an experimental or quasi-experimental design. Experimental designs include random assignment of participants, a control or comparison group in addition to the intervention group, and pre- and posttest assessments. Quasi-experimental designs include a control or comparison group and pre- and posttest assessments but do not use random assignment. Studies with single-group, pretest/posttest designs do not meet this requirement.
- The results of these studies have been published in a peer-reviewed journal or other professional publication (e.g., a book volume) or documented in a comprehensive evaluation report. Comprehensive evaluation reports must include the following sections or their equivalent: a review of the literature, theoretical framework, purpose, methodology, findings/results (with statistical analysis and p values for significant outcomes), discussion, and conclusions. Information must be included to enable rating of the six Quality of Research criteria.
- Implementation materials, training and support resources, and quality assurance procedures have been developed and are ready for use by the public.
The following types of interventions are not eligible for review:
- Stand-alone pharmacologic treatments. The evidence base for pharmacologic treatments is reviewed and approved through the U.S. Food and Drug Administration (FDA). FDA-approved pharmacotherapy interventions (on-label use) are considered for NREPP review only when combined with one or more behavioral or psychosocial treatments.
- Interventions that have been developed or evaluated with funds or other support, either partially or wholly, from organizations whose goals or activities are determined to be inconsistent with SAMHSA's mission.
For More Information
If you have any questions or comments about the open submission process or minimum requirements for review, please contact us by email at email@example.com, by phone at 1-866-43NREPP (1-866-436-7377), or through the online contact form.
Submissions Mailing List
Open submission is generally held annually. To receive announcements about future open submission periods, please join our Submissions mailing list by entering your email address below.